Skip to content

Clinical trials

Phase 3 Inflammatory Bowel Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 3 Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20044
20053
20066
20073
20084
20096
20102
201110
20125
20131
20143
20151
20163
20171
20184
20192
20203
20214
20221
20234
20244
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42
Terminated14
Unknown status8
Recruiting5
Active, not recruiting4
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch Health Americas, Inc.10
Janssen Research & Development, LLC5
Eli Lilly and Company4
Assistance Publique - Hôpitaux de Paris3
Pharmacosmos A/S3
Shield Therapeutics3
GlaxoSmithKline2
InDex Pharmaceuticals2
University Hospital, Grenoble2
University of Maryland, Baltimore2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases78
Colitis, Ulcerative34
Crohn Disease34
Anemia9
Anemia, Iron-Deficiency8
Colitis8
Iron Deficiencies8
Gastrointestinal Diseases7
Colonic Diseases5
Intestinal Diseases5

Trials

Showing 51 to 75 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.